-
EP3981793
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3981793
| EP3981793 - CEACAM5-RESISTANT MONOCLONAL ANTIBODY AND PREPARATION METHOD THEREOF AND USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 11.03.2022 Database last updated on 22.05.2024 | |
| Former | The international publication has been made Status updated on 11.12.2020 | Most recent event Tooltip | 02.04.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Biotheus Inc. 10B, Building 4 N°1 Keji 7th Road Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | [2022/15] | Inventor(s) | 01 /
MO, Shifu 101-7 ROOM NO. 332, AIDISHENG ROAD, CHINA ( SHANGHAI) PILOT FREE TRADE ZONE Shanghai 201203 / CN | 02 /
XU, Wei 101-7 ROOM NO. 332, AIDISHENG ROAD, CHINA ( SHANGHAI) PILOT FREE TRADE ZONE Shanghai 201203 / CN | 03 /
LUO, Yi 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | 04 /
CHEN, Liandi 10B, Building 4, No 1 Keji 7th Road, Tangjiawan Town, Xiangzhou District Zhuhai, Guangdong 519080 / CN | [2022/15] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2022/15] | Application number, filing date | 20818729.4 | 03.06.2020 | [2022/15] | WO2020CN94045 | Priority number, date | CN201910481112 | 04.06.2019 Original published format: CN201910481112 | [2022/15] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020244526 | Date: | 10.12.2020 | Language: | ZH | [2020/50] | Type: | A1 Application with search report | No.: | EP3981793 | Date: | 13.04.2022 | Language: | EN | [2022/15] | Search report(s) | International search report - published on: | CN | 10.12.2020 | (Supplementary) European search report - dispatched on: | EP | 08.05.2023 | Classification | IPC: | C07K16/30, C07K19/00, C12N15/63, A61P35/00, A61K39/00 | [2023/23] | CPC: |
A61P35/00 (EP,KR,US);
C07K16/3007 (EP,KR,US);
A61K39/4611 (EP,KR);
A61K39/4631 (EP,KR);
A61K39/464482 (EP,KR);
A61K47/6849 (US);
A61K48/005 (EP);
C07K14/7051 (EP);
C12N15/85 (US);
G01N33/57473 (EP,US);
A61K2039/505 (EP,KR,US);
A61K2039/572 (EP);
A61K2239/31 (EP,KR);
A61K2239/38 (EP,KR);
A61K2239/50 (EP,KR);
C07K2317/10 (US);
C07K2317/24 (EP,KR,US);
C07K2317/31 (KR);
C07K2317/56 (US);
C07K2317/565 (US);
C07K2317/622 (EP);
C07K2317/732 (EP,KR,US);
C07K2317/92 (EP,KR,US);
C07K2319/03 (EP);
|
| Former IPC [2022/15] | C07K16/30, C07K19/00, C12N15/63, A61K39/395, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/15] | Title | German: | CEACAM5-RESISTENTER MONOKLONALER ANTIKÖRPER UND VERFAHREN ZU SEINER HERSTELLUNG UND SEINE VERWENDUNG | [2022/15] | English: | CEACAM5-RESISTANT MONOCLONAL ANTIBODY AND PREPARATION METHOD THEREOF AND USE THEREOF | [2022/15] | French: | ANTICORPS MONOCLONAL ANTI-CEACAM5 ET SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION | [2022/15] | Entry into regional phase | 15.12.2021 | Translation filed | 15.12.2021 | National basic fee paid | 15.12.2021 | Search fee paid | 15.12.2021 | Designation fee(s) paid | 15.12.2021 | Examination fee paid | Examination procedure | 15.12.2021 | Examination requested [2022/15] | 28.11.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.06.2022 | Renewal fee patent year 03 | 31.03.2023 | Renewal fee patent year 04 | 31.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2015069430 (IMMUNOMEDICS INC [US]) [I] 1-25 * paragraphs [0003] , [0 13] - [0015] - [ 140] , [ 146] , [ 153]; examples 1-11 *; | [I]EP3009455 (IMMUNOMEDICS INC [US]) [I] 1-25 * the whole document *; | [I]EP3199552 (SANOFI SA [FR]) [I] 1-25 * the whole document *; | [A] - JYOTI MADHUSOODANAN, "With New CAR T Approach, City of Hope CEACAM Comes Full Circle", INTERNET CITATION, (20180209), pages 1 - 3, URL: https://www.cityofhope.org/breakthroughs/ceacam-research-comes-full-circle-thanks-to-new-car-t-approach, (20190829), XP009524319 [A] 15-22 * the whole document * | [A] - JUNE CARL H. ET AL, "CAR T cell immunotherapy for human cancer", SCIENCE, US, (20180323), vol. 359, no. 6382, doi:10.1126/science.aar6711, ISSN 0036-8075, pages 1361 - 1365, XP093042376 [A] 15-22 * the whole document * DOI: http://dx.doi.org/10.1126/science.aar6711 | International search | [X]CN102482701 (IMMUNOMEDICS INC) [X] 1-18, 22-25 * abstract, claims 1-60, sequence table *; | [A]CN103987729 (TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD, et al) [A] 1-18, 22-25 * entire description *; | [A]CN108341876 (FOURTH MILITARY MEDICAL UNIV PLA) [A] 1-18, 22-25* entire description *; | [X]CN109180815 (SANOFI SA) [X] 1-18, 22-25 * abstract, claims 1-39, sequence table * | by applicant | EP0404097 | WO9311161 | WO9404678 | WO9425591 | US6005079 | - AL-LAZIKANI, B.CHOTHIA, C.LESK, AM, J. Mol. Biol., (19970000), vol. 273, no. 4, page 927 | - CHOTHIA, C., J. Mol. Biol., (19850000), vol. 186, no. 3, pages 651 - 63 | - CHOTHIA, C.LESK, AM, J. Mol. Biol., (19870000), vol. 196, page 901 | - CHOTHIA, C. et al., Nature, (19890000), vol. 342, no. 6252, pages 877 - 83 | - HUSTON JS et al., Proc Natl Acad Sci USA, (19880000), vol. 85, page 5879 | - RIECHMANN L.MUYLDERMANS S., J Immunol Methods, (19990000), vol. 231, no. 1-2, pages 25 - 38 | - MUYLDERMANS S., J Biotechnol, (20010000), vol. 74, no. 4, pages 277 - 302 | - HAMERS CASTERMAN C. et al., Nature, (19930000), vol. 363, no. 6428, pages 446 - 8 | - NGUYEN VK. et al., "Heavy-chain antibodies in Camelidae: a case of evolutionary innovation", Immunogenetics, (20020000), vol. 54, no. 1, pages 39 - 47 | - NGUYEN VK. et al., Immunology, (20030000), vol. 109, no. 1, pages 93 - 101 | - KOCH-NOLTE F. et al., FASEB J, (20070000), vol. 21, no. 13, pages 3490 - 8 | - HOLLIGER P. et al., Proc Natl. Acad Sci US A., (19930000), vol. 90, no. 14, pages 6444 - 8 | - MORIMOTO et al., J. Biochem. Biophys. Methods, (19920000), vol. 24, pages 107 - 117 | - BRENNAN et al., Science, (19850000), vol. 229, page 81 | - HUDSON, Curr. Opin. Immunol., (19990000), vol. 11, pages 548 - 557 | - LITTLE et al., Immunol. Today, (20000000), vol. 21, pages 364 - 370 | - CARTER et al., Bio/Technology, (19920000), vol. 10, pages 163 - 167 | - GRAHAM et al., Gen Virol, (19770000), vol. 36, page 59 | - URLAUB et al., Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216 | - MATHER JP, Biol. Reprod., (19800000), vol. 23, pages 243 - 252 | - MATHER et al., Annals NY Acad. Sci., (19820000), vol. 383, pages 44 - 68 | - LINDMARK et al., J. Immunol. Meth., (19830000), vol. 62, page 13 | - GUSS et al., EMBO J, (19860000), vol. 5, pages 1567 - 1575 | - KABAT et al., Sequences of Proteins of Immunological Interest, Public Health Service, National Institutes of Health, (19910000), pages 647 - 669 |